Resources from the same session
328MO - The pivotal clinical study of IM19 CAR-T cells in the treatment of relapsed or refractory aggressive B cell non-Hodgkin lymphomas
Presenter: Yan Xie
Session: Mini oral session: Haematological malignancies
Resources:
Abstract
Slides
329MO - HLX208, a novel BRAF V600E inhibitor, in adult patients with Langerhans cell histiocytosis and/or Erdheim-Chester disease harbouring BRAF V600E mutation
Presenter: Xin-xin Cao
Session: Mini oral session: Haematological malignancies
Resources:
Abstract
Slides
Webcast
330MO - Pooled safety analysis of zanubrutinib monotherapy in Asian patients with B cell malignancies
Presenter: Won Seog Kim
Session: Mini oral session: Haematological malignancies
Resources:
Abstract
Slides
Webcast
Invited Discussant 328MO, 329MO and 330MO
Presenter: Koji Izutsu
Session: Mini oral session: Haematological malignancies
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mini oral session: Haematological malignancies
Resources:
Webcast
331MO - Comparing data distribution and prognosis of acute myeloid leukemia according to 5th WHO classification and international consensus
Presenter: Soo Jung Lee
Session: Mini oral session: Haematological malignancies
Resources:
Abstract
Slides
Webcast
332MO - Long-term toxicities after allogeneic HSCT with or without total body irradiation: A population-based study in Korea
Presenter: Byoung Hyuck Kim
Session: Mini oral session: Haematological malignancies
Resources:
Abstract
Slides
Webcast
Invited Discussant 331MO and 332MO
Presenter: Michelle Poon
Session: Mini oral session: Haematological malignancies
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mini oral session: Haematological malignancies
Resources:
Webcast
333MO - Treatment patterns in patients with mantle cell lymphoma: Updated report of the Asia-Pacific multinational retrospective registry study
Presenter: Dok Hyun Yoon
Session: Mini oral session: Haematological malignancies
Resources:
Abstract
Slides
Webcast